Radium-223 (Ra-223) in sequence or in concurrent use with abiraterone acetate (AA) or enzalutamide (E) in metastatic castration resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP)

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Concurrent Use ◽

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdw372.35 ◽

2016 ◽

Vol 27 ◽

pp. vi255 ◽

Cited By ~ 2

Author(s):

D. Heinrich ◽

S. Gillessen ◽

A. Heidenreich ◽

D. Keizman ◽

J.M. O'Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Alkaline Phosphatase ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdx423.007 ◽

2017 ◽

Vol 28 ◽

pp. vi19 ◽

Cited By ~ 1

Author(s):

G. Procopio ◽

G. Paganelli ◽

M. Cabria ◽

E. Cortesi ◽

M. Tucci ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Alkaline Phosphatase ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Radium-223 (Ra-223) Therapy after Abiraterone: Analysis of Symptomatic Skeletal Events (SSEs) in an International Early Access Program (iEAP) in Patients with Metastatic castration-Resistant Prostate Cancer (mCRPC)

Journal of Medical Imaging and Radiation Sciences ◽

10.1016/j.jmir.2019.03.122 ◽

2019 ◽

Vol 50 (1) ◽

pp. S40

Author(s):

Joe M. O’sullivan ◽

Kurt Miller ◽

Daniel Heinrich ◽

Joan Carles ◽

Manfred Wirth ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdx423.006 ◽

2017 ◽

Vol 28 ◽

pp. vi18-vi19 ◽

Cited By ~ 1

Author(s):

G. Paganelli ◽

G. Procopio ◽

M. Cabria ◽

E. Cortesi ◽

M. Tucci ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Bone Targeting ◽

Radium 223 ◽

Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2019.05.012 ◽

2019 ◽

Vol 17 (5) ◽

pp. 348-355.e5 ◽

Cited By ~ 6

Author(s):

Fred Saad ◽

Silke Gillessen ◽

Daniel Heinrich ◽

Daniel Keizman ◽

Joe M. O’Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Disease Characteristics ◽

Radium 223 ◽

Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

Annals of Oncology ◽

10.1093/annonc/mdw372.34 ◽

2016 ◽

Vol 27 ◽

pp. vi254

Author(s):

F. Saad ◽

A. Heidenreich ◽

D. Heinrich ◽

D. Keizman ◽

J.M. O'Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Bone Targeting ◽

Radium 223 ◽

Radium-223 in an international early access program (EAP): Effects of concomitant medication on overall survival in metastatic castration-resistant prostate cancer (mCRCP) patients.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5034 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5034-5034 ◽

Cited By ~ 10

Author(s):

Fred Saad ◽

Joan Carles ◽

Silke Gillessen ◽

Daniel Heinrich ◽

Jeremy Gratt ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Concomitant Medication ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Radium-223 (Ra-223) therapy after abiraterone (Abi): Analysis of symptomatic skeletal events (SSEs) in an international early access program (iEAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Annals of Oncology ◽

10.1093/annonc/mdy284.033 ◽

2018 ◽

Vol 29 ◽

pp. viii287 ◽

Cited By ~ 3

Author(s):

K. Miller ◽

D. Heinrich ◽

J.M. O’Sullivan ◽

J. Carles ◽

M. Wirth ◽

...

Keyword(s):

Prostate Cancer ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

BMC Cancer ◽

10.1186/s12885-018-5203-y ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 16

Author(s):

Axel Heidenreich ◽

Silke Gillessen ◽

Daniel Heinrich ◽

Daniel Keizman ◽

Joe M. O’Sullivan ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Metastases ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽

Asymptomatic Patients ◽

2561 Effects of concomitant use of abiraterone and/or enzalutamide with radium-223 on safety and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (EAP)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31380-6 ◽

2015 ◽

Vol 51 ◽

pp. S497-S498 ◽

Cited By ~ 4

Author(s):

J. O'Sullivan ◽

S. Gillessen ◽

A. Heidenreich ◽

D. Heinrich ◽

J. Gratt ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Early Access ◽

Castration Resistant ◽

Radium 223 ◽